Tower Research Capital LLC (TRC) - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,101
+94.1%
2,382
+143.3%
0.00%
Q2 2023$7,264
+242033.3%
979
+191.4%
0.00%
Q1 2023$3
-40.0%
336
-22.9%
0.00%
Q4 2022$5
-100.0%
436
-90.4%
0.00%
-100.0%
Q3 2022$33,000
+17.9%
4,565
-21.4%
0.00%0.0%
Q2 2022$28,000
+366.7%
5,806
+461.0%
0.00%
Q1 2022$6,000
+20.0%
1,035
+14.7%
0.00%
Q4 2021$5,000
+150.0%
902
+351.0%
0.00%
Q3 2021$2,000
-93.3%
200
-94.7%
0.00%
-100.0%
Q2 2021$30,000
+100.0%
3,808
+99.3%
0.00%
Q1 2021$15,000
+7.1%
1,911
+29.0%
0.00%
Q3 2020$14,0001,4810.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sentinus, LLC 149,050$1,408,5230.47%
Intrepid Financial Planning Group LLC 19,000$179,5500.09%
PERRITT CAPITAL MANAGEMENT INC 12,000$113,4000.06%
Interchange Capital Partners, LLC 11,413$107,8530.06%
Virtu Financial LLC 21,650$2050.02%
CREATIVE FINANCIAL DESIGNS INC /ADV 15,000$141,7500.02%
J. Goldman & Co LP 42,228$399,0550.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 63,966$604,4790.02%
KENNEDY CAPITAL MANAGEMENT LLC 46,311$437,6390.01%
683 Capital Management, LLC 16,000$151,2000.01%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders